New study: postpartum depression treatment may soon be available at home
NCT ID NCT05059600
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether the drug ZULRESSO (brexanolone) can be safely given to women with postpartum depression in their own homes instead of a hospital. Fifty-two women took part. The main goal was to see if any side effects caused the infusion to be stopped or interrupted. The results help show whether home treatment is a safe option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Brexanolone (ZULRESSO), a synthetic version of the hormone allopregnanolone, given as an intravenous infusion
What this could lead to
If successful, this could allow women with postpartum depression to receive treatment in the comfort of their own home instead of a hospital.
What could go wrong
This is a small, completed phase 4 study focused on safety and feasibility, not on how well the drug works. Home administration may still carry risks like infusion reactions or need for medical backup.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Culver City, California, 90230, United States
-
Sage Investigational Site
Miramar, Florida, 33029, United States
-
Sage Investigational Site
Pompano Beach, Florida, 33060, United States
-
Sage Investigational Site
New York, New York, 10036, United States
-
Sage Investigational Site
League City, Texas, 77573, United States
-
Virtual Site (recruiting nationwide)
Culver City, California, 90230, United States